MPG.eBooks - Author Search Results

61

CADTH Canadian Drug Expert Committee recommendation: Glecaprevir / Pibrentasvir (Maviret -- Abbvie Corporation) : indication : chronic hepatitis C virus infection

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

62

CADTH Canadian Drug Expert Committee recommendation: Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

63

CADTH Canadian Drug Expert Committee recommendation: Cysteamine delayed-release (Procysbi -- Horizon Pharma Ireland Ltd.) : indication : nephropathic cystinosis

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

64

CADTH CDEC final recommendation: Empagliflozin (Jardiance -- Boehringer Ingelheim (Canada) Ltd.) : indication : Type 2 Diabetes mellitus

Published 2015

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

65

CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection

Published 2014

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

66

CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease

Published 2015

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

67

CADTH Canadian Drug Expert Committee recommendation: Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

68

CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) : indication to reduce the subjective symptoms...

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

69

CADTH Canadian Drug Expert Committee recommendation: Daclizumab (Zinbryta -- Biogen Canada Inc.) : indication: relapsing-remitting multiple sclerosis

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

70

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

71

CADTH Canadian Drug Expert Committee recommendation: Netupitant/palonosetron (Akynzeo -- Purdue Pharma) : indication : chemotherapy-induced nausea and vomiting

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

72

CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

73

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

74

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

75

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

76

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

77

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

78

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion Pharmaceuticals Canada Inc.) : Indication: pulmonary arterial hypertension

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

79

CADTH Canadian Drug Expert Committee recommendation: Brexpiprazole (Rexulti - Lundbeck Canada Inc and Otsuka Canada Pharmaceutical Inc.) : indication : treatment of schizophrenia i...

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

80

CADTH Canadian Drug Expert Committee recommendation: Nitisinone (MDK-Nitisinone -- mendeliKABs inc.) : indication : the treatment of adult and pediatric patients with hereditary ty...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”